학술논문
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101)
Document Type
Article
Author
Babiker, H.; Borazenci, E.; Hultsch, R.; Subbiah, V.; Haymaker, C.; Bernatchez, C.; Murthy, R.; Diab, A.; Agarwala, S.; Algazi, A.; Schachter, J.; Lotem, M.; Kaplan, N.; Maurice-Dror, C.; Hendler, D.; Rahimian, S.; Chunduru, S.; Minderman, H.; Puzanov, I.; Mahadevan, D.; Woodhead, G.; Hennemeyer, C.; Anderson, P.M.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 1 December 2022, 28(23):5079-5087)
Subject
Language
English
ISSN
15573265
10780432
10780432